Clinical Trials Logo

Clinical Trial Summary

Ocular chemical burn is one of the causes of vision loss in China, and there are no satisfactory treatment. Human umbilical cord mesenchymal stem cells(UC-MSCs) have the biological characteristics of self-renewal, immune regulation, multidirectional differentiation and tissue repair. Our preliminary research showed that in corneal alkali injury rabbits, the UC-MSCs can accelerated the cornea repair, inhibited angiogenesis. The aim of this study is to access the efficacy and safety of UC-MSCs in the treatment of corneal burn in human.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03237442
Study type Interventional
Source Guangzhou Saliai Stem Cell Science and Technology Co. Ltd.
Contact Wanling Chen
Phone 0086-20-37792600
Email chenwanling@saliai.com
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date January 1, 2018
Completion date June 30, 2019